You have 9 free searches left this month | for more free features.

Eusa Pharma

Showing 1 - 25 of 210

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Large Granular Lymphocyte Leukemia Trial in Tampa (Siltuximab)

Recruiting
  • Large Granular Lymphocyte Leukemia
  • Tampa, Florida
    Moffitt Cancer Center
Mar 30, 2022

Leiomyosarcoma Trial in Bad Saarow, Berlin (Dinutuximab Beta, Zoledronic acid, Interleukin-2)

Recruiting
  • Leiomyosarcoma
  • Dinutuximab Beta, Zoledronic acid, Interleukin-2
  • Bad Saarow, Germany
  • +1 more
Jun 2, 2022

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta (Siltuximab, Spartalizumab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Siltuximab
  • Spartalizumab
  • Atlanta, Georgia
  • +2 more
Feb 1, 2022

Castleman Disease, Castleman's Disease, Giant Lymph Node Hyperplasia Trial in Worldwide

Recruiting
  • Castleman Disease
  • +8 more
    • Philadelphia, Pennsylvania
    • +9 more
    Dec 5, 2022

    Neuroblastoma Trial in Worldwide (Bevacizumab, Temozolomide, Irinotecan)

    Active, not recruiting
    • Neuroblastoma
    • Vienna, Austria
    • +9 more
    Feb 14, 2022

    Neuroblastoma Trial in Worldwide (Data-collection)

    Recruiting
    • Neuroblastoma
    • Data-collection
    • Wien,, Vienna, Austria
    • +13 more
    Oct 28, 2022

    Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

    Completed
    • Healthy
    • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
    • +2 more
    • Cairo, Egypt
      Genuine Research Center GRC
    Mar 2, 2023

    Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Canada, United States (asparaginase Erwinia chrysanthemi)

    Completed
    • Acute Lymphoblastic Leukemia
    • Lymphoblastic Lymphoma
    • asparaginase Erwinia chrysanthemi
    • Los Angeles, California
    • +21 more
    Jun 1, 2021

    Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)

    Recruiting
    • Bioequivalence
    • RID-TDS 13.3 mg/24 h
    • Exelon® 13.3 mg/24 h
    • Erfurt, Thüringen, Germany
      SocraTec R&D GmbH, Clinical Pharmacology Unit
    May 2, 2023

    Hypertension, Coronary Artery Disease Trial in Vadodara (Amlodipine Freeze-Dried Powder for Oral Solution 5 mg, Norvasc 5 mg

    Active, not recruiting
    • Hypertension
    • Coronary Artery Disease
    • Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
    • Norvasc 5 mg tablets of Pfizer Labs
    • Vadodara, Gujarat, India
      Accutest Research Laboratories (I) Pvt. Ltd.
    Apr 10, 2023

    Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)

    Recruiting
    • Glaucoma, Open-Angle
    • Ocular Hypertension
    • Olivos, Buenos Aires, Argentina
    • +5 more
    May 10, 2023

    Healthy Trial in Cairo (Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin))

    Completed
    • Healthy
    • Gleptomet 50/1000(Metformin HCl & Sitagliptin)
    • Janumet 50/1000(Metformin HCl & Sitagliptin)
    • Cairo, Egypt
      Genuine Research Center GRC
    Mar 22, 2023

    Healthy Volunteers Trial in Kistarcsa (BV100, Midazolam)

    Recruiting
    • Healthy Volunteers
    • Kistarcsa, Hungary
      CRU Hungary Kft., Early Phase Unit
    Sep 14, 2022

    Pregnancy Related, Nausea Trial in Moscow (Doxylamine + Pyridoxine)

    Recruiting
    • Pregnancy Related
    • Nausea
    • Doxylamine + Pyridoxine
    • Moscow, Russian Federation
      Llc "Certa Clinic"
    Aug 9, 2022

    Unresectable Angiosarcoma Trial in Tokyo (BNCT)

    Recruiting
    • Unresectable Angiosarcoma
    • BNCT
    • Tokyo, Japan
      National Cancer Center Hospital
    Nov 21, 2022

    Drug Use Trial in Jakarta (Glimepiride, Amaryl®)

    Completed
    • Drug Use
    • Jakarta, DKI Jakarta, Indonesia
      PT Pharma Metric Labs
    Jul 20, 2022

    Healthy Trial in Cairo (Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose), Nirmatrelvir 150 mg + Ritonavir 100 mg

    Recruiting
    • Healthy
    • Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose)
    • +2 more
    • Cairo, Egypt
      Genuine Research Center GRC
    Aug 4, 2022

    Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Boston (TAZEMETOSTAT, Zandelisib)

    Not yet recruiting
    • Relapsed Follicular Lymphoma
    • Refractory Follicular Lymphoma
    • Boston, Massachusetts
    • +1 more
    Oct 28, 2022

    Type 1 Diabetes, Hypoglycemia Trial in Bern (Micro-glucagon, Mini-glucagon)

    Not yet recruiting
    • Type 1 Diabetes
    • Hypoglycemia
    • Bern, Switzerland
      Department of Diabetes, Endocrinology, Nutritional Medicine and
    May 19, 2022

    Bioequivalence Trial in Erfurt (Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h)

    Active, not recruiting
    • Bioequivalence
    • Rivastigmine twice-weekly 9,5 mg/24 h
    • Exelon® 9.5 mg/24 h
    • Erfurt, Thuringia, Germany
      SocraTec R&D GmbH, Clinical Pharmacology Unit
    May 22, 2023

    Alveolar Ridge Trauma, Bone Resorption Trial in Padova (Bone grafting)

    Recruiting
    • Alveolar Ridge Trauma
    • Bone Resorption
    • Bone grafting
    • Padova, Italy
      Franci Institute
    Mar 29, 2022

    Dry Eye Disease Trial in Waterloo (0.09% cyclosporine A ophthalmic solution)

    Recruiting
    • Dry Eye Disease
    • 0.09% cyclosporine A ophthalmic solution
    • Waterloo, Ontario, Canada
      University of Waterloo
    Jul 13, 2023

    Type 2 Diabetes Trial in Zibo (14028 injection, dulaglutide injection)

    Recruiting
    • Type 2 Diabetes
    • 14028 injection
    • dulaglutide injection
    • Zibo, Shandong, China
      PKUCare Luzhong Hospital
    Jul 12, 2022

    Infertility, Female Trial in Bani Suwayf (Sildenafil Citrate, Clomiphene Citrate 50mg)

    Completed
    • Infertility, Female
    • Sildenafil Citrate
    • Clomiphene Citrate 50mg
    • Banī Suwayf, Egypt
      Beni-suef university
    Apr 26, 2023

    COVID-19 Vaccination Trial in Hong Kong (BNT162b2, CoronaVac)

    Active, not recruiting
    • COVID-19 Vaccination
    • BNT162b2
    • CoronaVac
    • Hong Kong, Hong Kong
      The University of Hong Kong
    Feb 8, 2022